Literature DB >> 15520152

Unsuspected acquired haemophilia in a patient with myocardial infarction.

P W X Foley1, D Pepperell, Rashid Kazmi, N P Curzen.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15520152      PMCID： PMC1079651          DOI： 10.1177/014107680409701110

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  6 in total

1.  Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab).

Authors:  Sam Kain; Tandy-Sue Copeland; Michael F Leahy
Journal:  Br J Haematol       Date:  2002-11       Impact factor: 6.998

2.  Acquired hemophilia: a critical bleeding syndrome.

Authors:  Francesco Baudo; Francesco de Cataldo
Journal:  Haematologica       Date:  2004-01       Impact factor: 9.941

Review 3.  Acquired haemophilia: an important but often unrecognised cause of bleeding in elderly people.

Authors:  E N Evans; R V Majer
Journal:  BMJ       Date:  1995-09-09

4.  Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors.

Authors:  S Arkin; F Blei; J Fetten; R Foulke; G S Gilchrist; M A Heisel; N Key; C T Kisker; C Kitchen; F E Shafer; P C Shah; D Strickland
Journal:  Blood Coagul Fibrinolysis       Date:  2000-04       Impact factor: 1.276

5.  Rituximab in the treatment of acquired factor VIII inhibitors.

Authors:  Adrian Wiestner; Hearn J Cho; Adam S Asch; Mary Ann Michelis; Jack A Zeller; Ellinor I B Peerschke; Babette B Weksler; Geraldine P Schechter
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

6.  Efficacy of 2-chlorodeoxyadenosine in refractory factor VIII inhibitors in persons without hemophilia.

Authors:  Sabah Sallah; Jim Y Wan
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.